Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;31(2):150-158.
doi: 10.1089/vim.2017.0146. Epub 2018 Jan 25.

Opinion: Making Inactivated and Subunit-Based Vaccines Work


Opinion: Making Inactivated and Subunit-Based Vaccines Work

Brendon Y Chua et al. Viral Immunol. .


Empirically derived vaccines have in the past relied on the isolation and growth of disease-causing microorganisms that are then inactivated or attenuated before being administered. This is often done without prior knowledge of the mechanisms involved in conferring protective immunity. Recent advances in scientific technologies and in our knowledge of how protective immune responses are induced enable us to rationally design novel and safer vaccination strategies. Such advances have accelerated the development of inactivated whole-organism- and subunit-based vaccines. In this review, we discuss ideal attributes and criteria that need to be considered for the development of vaccines and some existing vaccine platforms. We focus on inactivated vaccines against influenza virus and ways by which vaccine efficacy can be improved with the use of adjuvants and Toll-like receptor-2 signaling.

Keywords: Toll-like receptor-2; inactivated; subunit.

Similar articles

See all similar articles

Cited by 2 articles

MeSH terms

LinkOut - more resources